DJIA 16,631.38 16.57 0.10%
NASDAQ 4,430.31 10.83 0.25%
S&P 500 1,946.86 5.58 0.29%
market minute promo

43.34 1.51 (3.61%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ENTA $43.34 3.61%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.85
Previous Close $41.83
Daily Range $41.58 - $43.92
52-Week Range $18.79 - $48.49
Market Cap $805.4M
P/E Ratio 24.75
Dividend (Yield) $0.00 (0.0%)
Volume 140,619
Average Daily Volume 315,458
Current FY EPS $1.79

Sector

Industry

Enanta Pharmaceuticals, Inc. (ENTA) Description

Enanta Pharmaceuticals, Inc. Website: http://www.enanta.com/

News & Commentary Rss Feed

Why Is Sanofi Betting on MannKind Corporation's Afrezza?

Sanofi's global dominance over the lucrative diabetes market is facing a serious challenge with the patent expiration of Lantus, the most commonly prescribed insulin in the world. Can MannKind's inhaled insulin product help Sanofi retain its edge?

Enanta Pharmaceuticals (ENTA) Is Today's Dead Cat Bounce Stock

AbbVie Drops Shire Deal, Announces Buyback, Ups Dividend - Analyst Blog

Enanta (ENTA) Worth Watching: Stock Moves 6.9% Higher - Tale of the Tape

Weak On High Volume: Enanta Pharmaceuticals (ENTA)

Enanta Pharma Reports Update on Collaboration Deal with AbbVie: Will Not Exercise Option for Co-Deve

Enanta Pharma Reports Update on Collaboration Deal with AbbVie: Will Not Exercise Option for Co-Development, Co. Received $57M Related to Signing, $95M in Milestones

Enanta Pharmaceuticals (ENTA) Hits New Lifetime High

End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies

A Harvoni Vs. Olysio Price War Will Be Nonexistent: Consider Buying Gilead Now

ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape

Tetraphase (TTPH) Crumbles: Stock Tanks by 15% - Tale of the Tape

See More ENTA News...